Analytical Validation of an Immunohistochemical 7-Biomarker Prognostic Assay (immunoprint(®)) for Early-Stage Cutaneous Melanoma in Archival Tissue of Patients with AJCC v8 T2–T3 Disease

Selected patients with early-stage melanoma have a “hidden high risk” of poor oncologic outcomes. They might benefit from clinical trials, and ultimately, if warranted by trial results, judicious everyday use of adjuvant therapy. A promising tool to identify these individuals is the immunoprint(®) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziemer, Mirjana, Weidenthaler-Barth, Beate, Gussek, Philipp, Pfeiffer, Maja, Kleemann, Johannes, Bankov, Katrin, Wild, Peter J., Seibold, Silke, Sureshkumar, Priyavathi, Nickel, Patricia, Strobel, Anton, Werner, Markus, Grabbe, Stephan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572486/
https://www.ncbi.nlm.nih.gov/pubmed/37835839
http://dx.doi.org/10.3390/diagnostics13193096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10572486/
https://www.ncbi.nlm.nih.gov/pubmed/37835839
http://dx.doi.org/10.3390/diagnostics13193096

Ejemplares similares